Search

everythinglearnresearchcommunity

for

Search:↓

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Cepharanthine shows promise as a COVID-19 treatment.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Working in non-Covid-19 wards and night shifts is linked to higher infection rates among Italian nurses.

Skin and mucosal issues can occur after COVID-19 in adults and children.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Higher androgen levels might make COVID-19 worse, especially in men.

Testosterone may influence COVID-19 severity and outcomes.

Women with high androgen levels may have more severe COVID-19 symptoms.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Testosterone's effects on COVID-19 are unclear and need more research.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may cause temporary hair loss in some people.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Anti-androgens might help reduce COVID-19 severity in men.

COVID-19 may harm male fertility and damage the reproductive system.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Thuja orientalis and Thuja occidentalis essential oils have medicinal properties useful for developing treatments with antimicrobial and bioactive effects.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.